Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Recurrence ad Survival After Robotic Versus Laparoscopic Liver Resection in Very-early to Early (BCLC 0-A) Hepatocellular Carcinoma

NCT06496113 is registered in ClinicalTrials.gov with Ente Ospedaliero Cantonale, Bellinzona as lead sponsor.

NCT NCT06496113
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06496113 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Recurrence ad Survival After Robotic Versus Laparoscopic Liver Resection in Very-early to Early (BCLC 0-A) Hepatocellular Carcinoma
Lead sponsor
Ente Ospedaliero Cantonale, Bellinzona
Phase
Observational
Overall status
Completed
Start date
January 31, 2014
Completion date
June 30, 2024
Enrollment
196 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma